Post–COVID-19 conditions to consider monitoring for include autoimmune, respiratory/secondary infections, and tuberculosis.
As patients post–SARS-CoV-2 (COVID-19) infection report varying stages of fatigue and muscle weakness, detecting inflammation of the muscles and identifying cause can help inform appropriate treatment plans.
People who are ill with tuberculosis (TB) and other respiratory infectious diseases, such as SARS-CoV-2, influenza A/B, and RSV, often present with overlapping symptoms.
Throughout the year, there are high influenza-like respiratory issues like allergies and asthma across the country, according to the CDC.5,6 Asthma patients might be at an increased risk from COVID-19.7 Quest continues to offer influenza, RSV, and allergy testing, including influenza A/B + RSV to differentially diagnose influenza A/B and RSV, as well as ImmunoCAP® to diagnose respiratory allergies.
While experience on SARS-CoV-2 (COVID-19) infection in tuberculosis (TB) patients remains limited, it is anticipated that people ill with both TB and COVID-19 may have poorer treatment outcomes, especially if the TB treatment is interrupted.8 Quest offers convenient screening via TB blood testing, providing results after just 1 patient encounter.